Document Detail


Ofloxacin resistance mechanism in PA150 and PA300-clinical isolates of Pseudomonas aeruginosa in Korea.
MedLine Citation:
PMID:  9868535     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Five hundred and seventy clinical strains of Pseudomonas aeruginosa were isolated from August 1993 to August 1994 in Korea and screened for their resistance to ciprofloxacin, norfloxacin, and ofloxacin. Among these, two P. aeruginosa strains (PA150 and PA300) were selected based on their strong resistance (MICs > 50 micrograms/ml) to all three quinolones. The susceptible strain as well as two resistant strains had proton gradient-dependent efflux system. Efflux system in PA300 showed different specificities to ofloxacin and ciprofloxacin while PA 150 had less permeability for ofloxacin. Ofloxacin had a less inhibitory action on DNA synthesis in permeabilized cells of PA150 and PA300 than 1771M. When quinolone resistance determining region (QRDR) in gyrA was sequenced, PA300 had one missense mutation, Asn 116Tyr, which was newly reported in this work. The results showed that PA150 became ofloxacin resistant by reduced ofloxacin accumulation due to the existence of efflux system and low permeability, while resistance of PA300 was due to the efflux system and a mutation in QRDR of gyrA-the target site of quinolone.
Authors:
S Lee; Y Lee
Related Documents :
11918815 - An rrna mutation identifies the apicoplast as the target for clindamycin in toxoplasma ...
9401805 - Ciprofloxacin-resistant escherichia coli emerging in a rehabilitation medical center.
15190035 - Type ii topoisomerase mutations in bacillus anthracis associated with high-level fluoro...
16404155 - Molecular cloning of the dna gyrase genes from methylovorus sp. strain ss1 and the mech...
7986805 - Mechanism of alanine excretion in recombinant strains of zymomonas mobilis.
23315415 - Arenitalea lutea gen. nov., sp. nov., a marine bacterium of the family flavobacteriacea...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of pharmacal research     Volume:  21     ISSN:  0253-6269     ISO Abbreviation:  Arch. Pharm. Res.     Publication Date:  1998 Dec 
Date Detail:
Created Date:  1999-02-11     Completed Date:  1999-02-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8000036     Medline TA:  Arch Pharm Res     Country:  KOREA    
Other Details:
Languages:  eng     Pagination:  671-6     Citation Subset:  IM    
Affiliation:
Department of Biology, Seoul Women's University, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Base Sequence
Ciprofloxacin / pharmacology
DNA / biosynthesis
DNA Gyrase
DNA Topoisomerases, Type II / genetics
Drug Resistance, Microbial / physiology*
Humans
Korea
Ofloxacin / analysis,  pharmacokinetics,  pharmacology*
Pseudomonas aeruginosa / drug effects*,  genetics
Chemical
Reg. No./Substance:
82419-36-1/Ofloxacin; 85721-33-1/Ciprofloxacin; 9007-49-2/DNA; EC 5.99.1.-/DNA Gyrase; EC 5.99.1.3/DNA Topoisomerases, Type II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intracellular Ca2+ mediates lipoxygenase-induced proliferation of U-373 MG human astrocytoma cells.
Next Document:  Metabolism of an anionic fluorescent dye, 1-anilino-8-naphthalene sulfonate (ANS) by rat liver micro...